Adjuvant Avelumab in Merkel Cell Cancer

Clinical trial NCT03271372 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03271372
Sponsor: University of Washington
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Stage III Merkel Cell Carcinoma AJCC v8 Stage IIIB Merkel Cell Carcinoma AJCC v8 Stage IIIA Merkel Cell Carcinoma AJCC v8

Start date: 2017-12-19
Primary completion: 2029-01-31
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.